首页> 外国专利> Solid or liquid pharmaceutical preparations, containing as active substance cilansetron, use of the acid addition for the stabilizing of cilansetron against racemization in these pharmaceutical preparations and method for their preparation

Solid or liquid pharmaceutical preparations, containing as active substance cilansetron, use of the acid addition for the stabilizing of cilansetron against racemization in these pharmaceutical preparations and method for their preparation

机译:包含西兰司酮作为活性物质的固体或液体药物制剂,在这些药物制剂中使用酸加成稳定西兰司酮对抗外消旋的用途及其制备方法

摘要

Solid or liquid pharmaceutical preparations, containing as active substance cilansetron or its physiologically compatible acid addition salts in conventional therapeutically effective quantities in addition to at least one physiologically compatible water-soluble acid additive to stabilize the cilansetron against racemization, wherein in solid pharmaceutical preparations the molar ratio of water-soluble acid components to cilansetron in the preparation lies between 1.02 : 1 and 10 : 1, and the proportion of acid additives does not amount to over 50 % by weight of the preparation, and wherein liquid preparations represent aqueous solutions which have pH values between 2.5 and 4.5.
机译:固体或液体药物制剂,除了至少一种生理上相容的水溶性酸添加剂之外,还包含常规治疗有效量的西兰司酮或其生理相容性酸加成盐,以稳定西兰司酮抗外消旋作用,其中在固体药物制剂中,制剂中水溶性酸组分与西兰司酮的比例在1.02∶1至10∶1之间,并且酸添加剂的比例不超过制剂的50重量%,并且其中液体制剂代表具有以下特征的水溶液: pH值介于2.5和4.5之间。

著录项

  • 公开/公告号SK284916B6

    专利类型

  • 公开/公告日2006-02-02

    原文格式PDF

  • 申请/专利权人 SOLVAY PHARMACEUTICALS GMBH;

    申请/专利号SK100998A

  • 申请日1998-07-24

  • 分类号A61K9/08;A61K47;A61K9;A61K9/20;A61K31;A61K31/15;A61K31/415;A61K31/4164;A61K31/435;A61K31/47;A61K31/475;A61K47/12;A61P1/06;

  • 国家 SK

  • 入库时间 2022-08-21 21:37:43

相似文献

  • 专利
  • 外文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号